Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn’s disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Chronic inflammation in inflammatory bowel disease (IBD; Crohn's disease and ulcerative colitis) may be attributed partly to increased secretion of inflammatory cytokines. The aim of this study was to investigate simultaneously the spontaneous release patterns of tumor necrosis factor-alpha (TNF-alpha), interleukin-1-beta (IL-1 beta), and interleukin-6 (IL-6) by organ cultures of inflamed mucosa from IBD patients. Organ cultures of involved IBD mucosa spontaneously produced increased amounts of TNF-alpha, IL-1 beta, and IL-6 compared to normal mucosa. The patterns of cytokine release between Crohn's disease and ulcerative colitis organ cultures were not significantly different. Increased inflammatory cytokine production by lamina propria mononuclear cells (LPMCs) and mucosa treated with EDTA suggests that these cytokines originate mainly from LPMCs. These results confirm the role of inflammatory cytokines in IBD and shed a new light on the role of TNF-alpha in IBD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“that are necessary and sufficient to induce villus injury and compromise intestinal barrier function.”
From Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (2016) · cites this paper as [40]
In the citing paper
“The same cytokines have been reported to be up-regulated in clinical studies of human inflammatory diseases, including in patients with active ulcerative colitis patients (41), Crohn's disease (40), and pouchitis (42).”
From Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (2016) · cites this paper as [40]
Citations
Cites
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146 · cited 2×
“However, long-term effectiveness of anti-TNF-a antibodies required continuous administration of the antibody (16, 17 ).”
BackgroundTreatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
Powrie, F., Correa-Oliveira, R., Mauze, S., & Coffman, R. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.589 · Cited by 613
Breese, E. J., Michie, C. A., Nicholls, S. W., Murch, S. H., Williams, C. B., Domizio, P., Walker-Smith, J. A., & Macdonald, T. T. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90398-0 · Cited by 566
Microscopic activity in ulcerative colitis: what does it mean?
Riley, S. A., Mani, V, Goodman, M. J., Dutt, S., & Herd, M. E. (1991) · Gut · doi:10.1136/gut.32.2.174 · Cited by 564
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1954) · BMJ · doi:10.1136/bmj.2.4884.375 · Cited by 538
Murch, S. H., Braegger, C. P., Walker-Smith, J. A., & MacDonald, T. T. (1993) · Gut · doi:10.1136/gut.34.12.1705 · Cited by 520
MACDONALD, T. T., HUTCHINGS, P., CHOY, M.-Y., MURCH, S., & COOKE, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb03334.x · Cited by 478
Cited by
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin
Carballo, E., Lai, W. S., & Blackshear, P. J. (1998) · Science · doi:10.1126/science.281.5379.1001 · Cited by 1,161
Rutgeerts, P., D'Haens, G., Targan, S., Vasiliauskas, E., Hanauer, S. B., Present, D. H., Mayer, L., Van Hogezand, R. A., Braakman, T., DeWoody, K. L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70332-x · Cited by 1,080
Kim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Heazlewood, C. K., Cook, M. C., Eri, R., Price, G. R., Tauro, S. B., Taupin, D., Thornton, D. J., Png, C. W., Crockford, T. L., Cornall, R. J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050054 · Cited by 701
Role of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699
Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases
Hart, A. L., Al-Hassi, H. O., Rigby, R. J., Bell, S. J., Emmanuel, A. V., Knight, S. C., Kamm, M. A., & Stagg, A. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.013 · Cited by 564
Infliximab for the treatment of fistulas in patients with Crohn's disease
Ricart, E., & Sandborn, W. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70414-2 · Cited by 519
Cytokines in Inflammatory Bowel Disease
Rogler, G., & Andus, T. (1998) · World Journal of Surgery · doi:10.1007/s002689900401 · Cited by 484
Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium
Günther, C., Neumann, H., Neurath, M. F., & Becker, C. (2013) · Gut · doi:10.1136/gutjnl-2011-301364 · Cited by 462
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
Sands, B. E., Tremaine, W. J., Sandborn, W. J., Rutgeerts, P. J., Hanauer, S. B., Mayer, L., Targan, S. R., & Podolsky, D. K. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00001 · Cited by 422
Immune response and inflammatory pathway of ulcerative colitis
Tatiya-aphiradee, N., Chatuphonprasert, W., & Jarukamjorn, K. (2018) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2018-0036 · Cited by 368
Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Kenney, J. S., Baumann, R., Poindron, P., & Duclos, B. (1996) · Gut · doi:10.1136/gut.39.5.684 · Cited by 297
Self-citationWehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K. R., Fellermann, K., Schroeder, J. M., & Stange, E. F. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00001 · Cited by 295
Immune dysfunction in inflammatory bowel disease
Neuman, M. G. (2007) · Translational Research · doi:10.1016/j.trsl.2006.11.009 · Cited by 255
Changes of the cytokine profile in inflammatory bowel diseases
Műzes, G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5848 · Cited by 250
Nagy, L. E. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800803 · Cited by 228
Billmeier, U., Dieterich, W., Neurath, M. F., & Atreya, R. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9300 · Cited by 208
Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro
Vos, A. C. W., Wildenberg, M. E., Arijs, I., Duijvestein, M., Verhaar, A. P., de Hertogh, G., Vermeire, S., Rutgeerts, P., van den Brink, G. R., & Hommes, D. W. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21818 · Cited by 200
Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice
Popivanova, B. K., Kostadinova, F. I., Furuichi, K., Shamekh, M. M., Kondo, T., Wada, T., Egashira, K., & Mukaida, N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1451 · Cited by 200
Thakur, V., Pritchard, M. T., McMullen, M. R., Wang, Q., & Nagy, L. E. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005613 · Cited by 196
Tissue cytokine and chemokine expression in inflammatory bowel disease
McCormack, G., Moriarty, D., O'Donoghue, D. P., McCormick, P. A., Sheahan, K., & Baird, A. W. (2001) · Inflammation Research · doi:10.1007/pl00000223 · Cited by 181
Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis
Su, C. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04384-8 · Cited by 175
Ishida, T., Yoshida, M., Arita, M., Nishitani, Y., Nishiumi, S., Masuda, A., Mizuno, S., Takagawa, T., Morita, Y., Kutsumi, H., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21029 · Cited by 170
Octacosanol Attenuates Inflammation in Both RAW264.7 Macrophages and a Mouse Model of Colitis
Guo, T., Lin, Q., Li, X., Nie, Y., Wang, L., Shi, L., Xu, W., Hu, T., Guo, T., & Fei-jun, L. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b05465 · Cited by 145
INFLUENCE OF GLUTAMINE ON CYTOKINE PRODUCTION BY HUMAN GUT IN VITRO
Coëffier, M., Miralles-Barrachina, O., Pessot, F. L., Lalaude, O., Daveau, M., Lavoinne, A., Lerebours, É., & Déchelotte, P. (2001) · Cytokine · doi:10.1006/cyto.2000.0813 · Cited by 150
Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsies
Pinna, G., Fiorucci, M., Reimund, J., Taquet, N., Arondel, Y., & Muller, C. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.186 · Cited by 141
Self-citationEri, R. D., Adams, R. J., Tran, T. V., Tong, H., Das, I., Roche, D. K., Oancea, I., Png, C. W., Jeffery, P. L., Radford-Smith, G. L., et al. (2011) · Mucosal Immunology · doi:10.1038/mi.2010.74 · Cited by 131
Exploring the role of IL-1β in inflammatory bowel disease pathogenesis
Aggeletopoulou, I., Kalafateli, M., Tsounis, E. P., & Triantos, C. K. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1307394 · Cited by 158
Systematic review: infliximab therapy in ulcerative colitis
Gisbert, J. P., González‐Lama, Y., & MATÉ, J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03131.x · Cited by 147
Ng, S. C., Benjamin, J. L., McCarthy, N. E., Hedin, C. R. H., Koutsoumpas, A., Plamondon, S., Price, C. L., Hart, A. L., Kamm, M. A., Forbes, A., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21590 · Cited by 121
Remicade® Does Not Abolish the Need for Surgery in Fistulizing Crohn's Disease
Poritz, L. S., Rowe, W. A., & Koltun, W. A. (2002) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6296-8 · Cited by 126
Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study
Ochsenkühn, T., Sackmann, M. F., & Göke, B. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00014 · Cited by 124
Raddatz, D., hl, M. B., & Ramadori, G. P. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200505000-00012 · Cited by 135
Jagannath, B., Lin, K., Pali, M. L., Sankhala, D., Muthukumar, S., & Prasad, S. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa191 · Cited by 126
Onken, J. E., Greer, P. K., Calingaert, B., & Hale, L. P. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.11.002 · Cited by 120
Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis
Wang, Y., Tang, Q., Duan, P., & Yang, L. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1469145 · Cited by 112
Demyelination During Anti-Tumor Necrosis Factor α Therapy With Infliximab for Crohn's Disease
Thomas, C. W., Weinshenker, B. G., & Sandborn, W. J. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200401000-00004 · Cited by 118
McMullen, M. R., Pritchard, M. T., Wang, Q., Millward, C. A., Croniger, C. M., & Nagy, L. E. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.065 · Cited by 119
Alavi, K., Schwartz, M. Z., Palazzo, J., & Prasad, R. (2000) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2000.6861 · Cited by 113
Martínez-Borra, J., López‐Larrea, C., Gonzalez, S. R., Fuentes, D., Dieguez, A., Deschamps, E. M., Perez-Pariente, J. M., López‐Vázquez, A., de Francisco, R., & Rodrigo, L. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05990.x · Cited by 111
Does Infliximab Infusion Impact Results of Operative Treatment for Crohn's Perianal Fistulas?
Gaertner, W. B., Decanini, A., Mellgren, A. F., Lowry, A. C., Goldberg, S. M., Madoff, R. D., & Spencer, M. P. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9077-3 · Cited by 111
Newberry, R. D., McDonough, J. S., Stenson, W. F., & Lorenz, R. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4465 · Cited by 110
Inhibition of IL-12 Production in Human Monocyte-Derived Macrophages by TNF
Ma, X., Sun, J., Papasavvas, E., Riemann, H., Robertson, S., Marshall, J., Bailer, R. T., Moore, A., Donnelly, R. P., Trinchieri, G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1722 · Cited by 109
Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review
Marchioni, R. M., & Lichtenstein, G. R. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i17.2591 · Cited by 118
Stabilization of Tumor Necrosis Factor α mRNA by Chronic Ethanol
Kishore, R., McMullen, M. R., & Nagy, L. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107181200 · Cited by 108
Cytokines in inflammatory bowel disease
Moldoveanu, A. C., Diculescu, M., & Fierbinteanu-Braticevici, C. G. (2015) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2015-0016 · Cited by 113
Gornet, J., Couve, S., Hassani, Z., Delchier, J. C., Marteau, P. R., Cosnes, J., Bouhnik, Y., Dupas, J. L., Modigliani, R., Taillard, F., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01686.x · Cited by 104
Roth, S., Spalinger, M. R., Gottier, C., Biedermann, L., Zeitz, J., Lang, S., Weber, A., Rogler, G., & Scharl, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154817 · Cited by 106
The role of cytokine mRNA stability in the pathogenesis of autoimmune disease
Seko, Y., Cole, S. W., Kasprzak, W. K., Shapiro, B. A., & Ragheb, J. A. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.10.013 · Cited by 107
Infliximab in the surgical management of complex fistulating anal Crohn's disease
Talbot, C., Sagar, P. M., Johnston, M. J., Finan, P. J., & Burke, D. (2005) · Colorectal Disease · doi:10.1111/j.1463-1318.2004.00749.x · Cited by 95
Cantor, M. J., Nickerson, P. W., & Bernstein, C. N. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40979.x · Cited by 104
Jones-Hall, Y. L., Kozik, A., & Nakatsu, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119441 · Cited by 81
Infliximab Efficacy in Pediatric Ulcerative Colitis
Eidelwein, A. P., Cuffari, C., Abadom, V., & Oliva‐Hemker, M. M. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160803.44449.a5 · Cited by 85
Corbaz, A., ten Hove, T., Herren, S., Graber, P., Schwartsburd, B. I., Belzer, I., Harrison, J., Plitz, T., Kosco‐Vilbois, M. H., Kim, S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3608 · Cited by 85
Kohn, A., Prantera, C., Pera, A., Cosintino, R., Sostegni, R., & Daperno, M. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80204-3 · Cited by 85
Influence of deoxynivalenol on NF-κB activation and IL-8 secretion in human intestinal Caco-2 cells
Walle, J. V. D., Romier, B., Larondelle, Y., & Schneider, Y. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.01.018 · Cited by 84
New therapeutic strategies for treatment of inflammatory bowel disease
Atreya, R. N., & Neurath, M. F. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.7 · Cited by 98
TARGETING TUMOUR NECROSIS FACTOR ALPHA
LaDuca, J. R., & Gaspari, A. A. (2001) · Dermatologic Clinics · doi:10.1016/s0733-8635(05)70304-1 · Cited by 97
Antioxidant and immune status in active Crohn's disease. A possible relationship
Reimund, J. M., Hirth, C., Koehl, C., Baumann, R., & Duclos, B. (2000) · Clinical Nutrition · doi:10.1054/clnu.1999.0073 · Cited by 83
Self-citationDietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study
Olendzki, B. C., Bucci, V., Cawley, C., Maserati, R., McManus, M. M., Olednzki, E., Madziar, C., Chiang, D., Ward, D. V., Pellish, R. S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2046244 · Cited by 87
Fazio, L. D., Cavazza, E., Spisni, E., Strillacci, A., Centanni, M., Candela, M., Praticò, C., Campieri, M., Ricci, C., & Valerii, M. C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i8.2051 · Cited by 90
Methionine restriction on oxidative stress and immune response in dss-induced colitis mice
Liu, G., Yu, L., Fang, J., Hu, C.-A. A., Yin, J., Ni, H., Ren, W., Duraipandiyan, V., Chen, S., Al-Dhabi, N. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17812 · Cited by 79
Dietary Regulation of Intestinal Gene Expression
Sanderson, I. R., & Naik, S. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.311 · Cited by 84
Cell-type–restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
Efimov, G. A., Kruglov, A., Khlopchatnikova, Z. V., Rozov, F. N., Mokhonov, V. V., Rose‐John, S., Scheller, J., Gordon, S., Stacey, M. A., Drutskaya, M. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520175113 · Cited by 78
Rana, S. V., Sharma, S. K., Kaur, J., Prasad, K. K., Sinha, S. K., Kochhar, R. K., Malik, A., & Morya, R. K. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.01.007 · Cited by 78
Margulies, S. L., Kurian, D., Elliott, M. S., & Han, Z. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12283 · Cited by 82
Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model
Jakobsen, M., Stenderup, K., Rosada, C., Moldt, B., Kamp, S., Dam, T. N., Jensen, T. G., & Mikkelsen, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.141 · Cited by 76
Jang, H., Kim, J.-K., Joo, M.-K., Shin, Y.-J., Lee, C. K., Kim, H. J., & Kim, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-00088-x · Cited by 79
van Langenberg, D. R., Gatta, P. A. D., Hill, B., Zacharewicz, E., Gibson, P. R., & Russell, A. P. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.11.024 · Cited by 76
Murakami, H., Akbar, S. M. F., Matsui, H., & Onji, M. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00796.x · Cited by 73
Reimund, J., Dumont, S., Muller, C. D., Kenney, J. S., Kédinger, M., Baumann, R., Poindron, P., & Duclos, B. (1997) · Gut · doi:10.1136/gut.40.4.475 · Cited by 73
Self-citationInflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II)
Chandran, P., Satthaporn, S., Robins, A., & Eremin, O. (2003) · The Surgeon · doi:10.1016/s1479-666x(03)80091-4 · Cited by 80
The Intersection of TNF, IBD and the Microbiome
Jones‐Hall, Y., & Nakatsu, C. H. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1121364 · Cited by 73
Adesso, S., Autore, G., Quaroni, A., Popolo, A., Severino, L., & Marzocco, S. (2017) · Nutrients · doi:10.3390/nu9121343 · Cited by 69
Cytokine Networks in Ulcerative Colitis
Roda, G., Marocchi, M., Sartini, A., & Roda, E. (2011) · Ulcers · doi:10.1155/2011/391787 · Cited by 67
Nemetz, A., Tóth, M., García-González, M. A., Zágoni, T., Fehér, J., Peña, A. S., & Tulassay, Z. (2001) · Gut · doi:10.1136/gut.49.5.644 · Cited by 66
Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation
McEntee, C. P., Finlay, C. M., & Lavelle, E. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01266 · Cited by 70
Boirivant, M., & Cossu, A. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01811.x · Cited by 84
Wild, G., Waschke, K. A., Bitton, A., & Thomson, A. B. R. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01611.x · Cited by 72
Novel genetic markers in inflammatory bowel disease
Rodríguez-Bores, L., Fonseca, G.-C., Villeda, M.-A., & Yamamoto-Furusho, J.-K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i42.5560 · Cited by 70
Proinflammatory response and IL-12 expression in HIV-1 infection
Ma, X., & Montaner, L. J. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.3.383 · Cited by 66
Sands, B. E., Katz, S., Wolf, D. C., Feagan, B. G., Wang, T., Gustofson, L., Wong, C. J., Vandervoort, M. K., & Hanauer, S. B. (2012) · Gut · doi:10.1136/gutjnl-2011-300995 · Cited by 60
Maor, I., Rainis, T., Lanir, A., & Lavy, A. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0141-6 · Cited by 57
Kankuri, E. M., Hämäläinen, M., Hukkanen, M., Salmenperä, P., Kivilaakso, E. O., Vapaatalo, H., & Moilanen, E. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000681 · Cited by 60
Akazawa, A., Sakaida, I., Higaki, S., Kubo, Y., Uchida, K., & Okita, K. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200048 · Cited by 57
T cells and cytokines in Crohn's disease
Romagnani, P., Annunziato, F., Baccari, M. C., & Parronchi, P. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80180-x · Cited by 57
Côté, M., Poirier, A.-A., Aubé, B., Jobin, C., Lacroix, S., & Soulet, D. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.009 · Cited by 58
Lapointe, T. K., O’Connor, P. M. J., Jones, N. L., Ménard, D., & Buret, A. G. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01429.x · Cited by 61
Kaliora, A. C. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.45.6031 · Cited by 57
McMullen, M. R., Cocuzzi, E., Hatzoglou, M., & Nagy, L. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304566200 · Cited by 54
Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis
Bermejo, F., López–Sanromán, A., Hinojosa, J., de Castro, L., Jurado, C., & Gómez-Belda, A. B. (2004) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082004000200002 · Cited by 60
Tumor Necrosis Factor-Alpha Polymorphisms in Ulcerative Colitis-Associated Colorectal Cancer
Garrity-Park, M. M., Loftus, E. V., Bryant, S. C., Sandborn, W. J., & Smyrk, T. C. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01572.x · Cited by 60
Malo, M. S., Biswas, S., Abedrapo, M. A., Yeh, L., Chen, A., & Hodin, R. A. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.684 · Cited by 59
Brown, K. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04388-5 · Cited by 54
Cho, H., Lasco, T. M., Allen, S. S., Yoshimura, T., & McMurray, D. N. (2005) · Infection and Immunity · doi:10.1128/iai.73.3.1367-1376.2005 · Cited by 52
Evans, S. M., Ashwood, P., Warley, A., Berisha, F., Thompson, R. P. H., & Powell, J. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36554 · Cited by 51
Pearl, D. S., Shah, K., Whittaker, M. A., Nitch‐Smith, H., Brown, J. F., Shute, J. K., & Trebble, T. M. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.07.022 · Cited by 54
Optimal vitamin D levels in Crohn's disease: a review
Raftery, T. C., & OʼSullivan, M. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114001591 · Cited by 56
Metadata
- Authors
- Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Baumann, R., Poindron, P., & Duclos, B.
- Affiliations
- Hôpital d'Hautepierre (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- ORCID
- Muller, C. D.
- Venue
- Journal of Clinical Immunology
- Published
- 1996-05
- Volume
- 16
- Issue
- 3
- Pages
- 144-150
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W2047398409
- Cited by
- 281
- References
- 30
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 13 · 2014: 15 · 2013: 10 · 2012: 11
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- inflammatory bowel disease, ulcerative colitis, Crohn's disease, inflammatory cytokines, TNF-α, IL-1β, interleukin-6, mucosal inflammation, organ culture, lamina propria mononuclear cells, EDTA
- MeSH terms
- Adult, Aged, Colitis, Ulcerative, Crohn Disease, Female, Humans, Interleukin-1, Intestinal Mucosa, Male, Middle Aged, Organ Culture Techniques, Prospective Studies, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.